Arcadia Biosciences Inc Cash Flow Conversion Efficiency
Arcadia Biosciences Inc cash flow conversion efficiency. Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) has a cash flow conversion efficiency ratio of -0.208x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-861.00K) by net assets ($4.14 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Arcadia Biosciences Inc (2012–2025)
Cash flow conversion efficiency of Arcadia Biosciences Inc from 2012 to 2025. This chart illustrates how Arcadia Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RKDA share price today for real-time trading data and today's change.
Arcadia Biosciences Inc Cash Flow Conversion Ratio Explained
Arcadia Biosciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Arcadia Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arcadia Biosciences Inc ranked by their cash flow conversion efficiency. Also see Arcadia Biosciences Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sealand Capital Galaxy Ltd
LSE:SCGL
|
-0.037x |
|
EPWK Holdings Ltd. Class A
NASDAQ:EPWKF
|
0.517x |
|
Aberdeen Diversified Income and Growth Trust PLC
LSE:ADIG
|
0.004x |
|
CELLECTAR NEW22 DL-00001
F:NV4
|
N/A |
|
Angling Direct PLC
LSE:ANG
|
0.153x |
|
Henderson Diversified Income Trust PLC
LSE:HDIV
|
0.000x |
|
Pebble Beach Systems Group PLC
LSE:PEB
|
0.350x |
|
Ariana Resources plc
LSE:AAU
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Arcadia Biosciences Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Arcadia Biosciences Inc from 2012 to 2025. Review Arcadia Biosciences Inc financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.14 Million | $-4.74 Million | -1.145x | +26.01% |
| 2024-12-31 | $6.22 Million | $-9.63 Million | -1.547x | -28.49% |
| 2023-12-31 | $12.70 Million | $-15.29 Million | -1.204x | -80.03% |
| 2022-12-31 | $20.90 Million | $-13.98 Million | -0.669x | +19.35% |
| 2021-12-31 | $31.20 Million | $-25.87 Million | -0.829x | +21.65% |
| 2020-12-31 | $28.55 Million | $-30.22 Million | -1.058x | +48.76% |
| 2019-12-31 | $8.33 Million | $-17.20 Million | -2.066x | -94.19% |
| 2018-12-31 | $12.81 Million | $-13.63 Million | -1.064x | +39.01% |
| 2017-12-31 | $8.01 Million | $-13.96 Million | -1.744x | -127.00% |
| 2016-12-31 | $22.20 Million | $-17.05 Million | -0.768x | -104.55% |
| 2015-12-31 | $40.23 Million | $-15.11 Million | -0.376x | -104.79% |
| 2014-12-31 | $-1.89 Million | $-14.79 Million | 7.845x | +1292.38% |
| 2013-12-31 | $-17.30 Million | $-9.74 Million | 0.563x | -66.60% |
| 2012-12-31 | $-5.68 Million | $-9.59 Million | 1.687x | -- |
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more